| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |